Royalty Pharma PLC 10K Form

Sell

32

RPRX
Royalty Pharma PLC

Last Price:

$24.97

Seasonality Move:

1.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	RPRX/Royalty Pharma PLC Quarterly
2023-11-08	10Q	RPRX/Royalty Pharma PLC Quarterly
2023-08-08	10Q	RPRX/Royalty Pharma PLC Quarterly
2023-05-09	10Q	RPRX/Royalty Pharma PLC Quarterly
2022-11-08	10Q	RPRX/Royalty Pharma PLC Quarterly
2022-08-04	10Q	RPRX/Royalty Pharma PLC Quarterly

Receive RPRX News And Ratings

See the #1 stock for the next 7 days that we like better than RPRX

RPRX Financial Statistics

Sales & Book Value

Annual Sales:	$2.4B
Cash Flow:	$703.6M
Price / Cash Flow:	5.31
Annual Sales:	$15.40
Price / Book:	1.61

Profitability

EPS (TTM):	2.55000
Net Income (TTM):	$1.1B
Gross Margin:	$0
Return on Equity:	11.56%
Return on Assets:	6.81%

Royalty Pharma PLC Earnings Forecast

Key Royalty Pharma PLC Financial Ratios

The Gross Profit Margin over the past 11 years for RPRX is 0.00%.
The Selling, General & Administrative Expenses for RPRX have been equal to 10.61% of Gross Profit Margin.
The Research & Development expenses have been 2.21% of Revenue.
The Interest Expense is 16.49% of Operating Income.
The Net Earning history of RPRX is 48.20% of Total Revenues.
Per Share Earnings over the last 19 years have been positive in 10 years.

Royalty Pharma PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	RPRX
CUSIP:	G7709Q
Website:	royaltypharma.com

Debt

Debt-to-Equity Ratio:	1.11
Current Ratio:	1.54
Quick Ratio:	1.53

Price-to-Earnings

Trailing P/E Ratio:	9.86
Forward P/E Ratio:	5.95

RPRX Technical Analysis vs Fundamental Analysis

Sell

32

Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy or a Sell?

Royalty Pharma PLC stock is rated a Sell

The current Royalty Pharma PLC [RPRX] share price is $24.94. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.